| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.34 | 2e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |